What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Surgery
Douglas B. Evans mostly deals with Surgery, Pancreatic cancer, Pancreatic disease, Pancreas and Cancer research.
Douglas B. Evans interconnects Neoadjuvant therapy, Growth factor and Oncology in the investigation of issues within Pancreatic cancer.
His research on Pancreatic disease also deals with topics like
- Adenocarcinoma that intertwine with fields like Multimodality Therapy and Lymph node,
- Metastasis, which have a strong connection to Pathology.
His Pancreas research incorporates themes from Growth factor receptor, Radiology and Superior mesenteric vein.
His Cancer research research integrates issues from Carcinogenesis, Regulation of gene expression, Transcription factor and Pancreatic tumor.
His biological study spans a wide range of topics, including Gastroenterology and Endocrinology.
His most cited work include:
- One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States (2896 citations)
- Medullary thyroid cancer: management guidelines of the American Thyroid Association. (995 citations)
- Management of thyroid nodules detected at US: Society of radiologists in ultrasound consensus conference statement (875 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Pancreatic cancer, Internal medicine, Surgery, Oncology and Adenocarcinoma.
His Pancreatic cancer study incorporates themes from Neoadjuvant therapy, Cancer research, Chemotherapy, Radiation therapy and Pancreatic disease.
As a part of the same scientific study, Douglas B. Evans usually deals with the Internal medicine, concentrating on Pathology and frequently concerns with Metastasis.
His studies in Surgery integrate themes in fields like Parathyroidectomy and Radiology.
The Oncology study combines topics in areas such as CA19-9, Borderline resectable and Disease.
His study in Adenocarcinoma is interdisciplinary in nature, drawing from both Surgical oncology, General surgery and Pancreas.
He most often published in these fields:
- Pancreatic cancer (39.69%)
- Internal medicine (35.78%)
- Surgery (30.47%)
What were the highlights of his more recent work (between 2015-2021)?
- Pancreatic cancer (39.69%)
- Internal medicine (35.78%)
- Oncology (25.31%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Pancreatic cancer, Internal medicine, Oncology, Neoadjuvant therapy and Surgery.
His studies deal with areas such as Cancer research, Pancreatectomy, Borderline resectable, Disease and Adjuvant therapy as well as Pancreatic cancer.
His study in the fields of Cancer, Chemotherapy and Gemcitabine under the domain of Internal medicine overlaps with other disciplines such as In patient.
Pancreas is closely connected to Neuroendocrine tumors in his research, which is encompassed under the umbrella topic of Oncology.
His research integrates issues of Clinical trial and Multimodality Therapy, Chemoradiotherapy, Radiation therapy, Overall survival in his study of Neoadjuvant therapy.
He has researched Surgery in several fields, including Parathyroidectomy, Adrenocortical carcinoma and Thyroidectomy.
Between 2015 and 2021, his most popular works were:
- Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models. (93 citations)
- Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience. (87 citations)
- Survival of patients with resectable pancreatic cancer who received neoadjuvant therapy. (85 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Surgery
Douglas B. Evans mainly focuses on Surgery, Pancreatic cancer, Internal medicine, Neoadjuvant therapy and Retrospective cohort study.
His Surgery research is multidisciplinary, incorporating elements of Parathyroidectomy, Adrenocortical carcinoma and Urology.
His Pancreatic cancer study integrates concerns from other disciplines, such as Stromal cell, Cancer research, Combined Modality Therapy, Radiology and Adjuvant therapy.
Douglas B. Evans interconnects Pancreaticoduodenectomy, Pancreas and Endocrine system in the investigation of issues within Radiology.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Oncology.
His biological study spans a wide range of topics, including Borderline resectable and Radiation therapy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
